{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:11:40Z","timestamp":1761091900718,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Nursing"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jvn.2014.01.004","type":"journal-article","created":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T12:43:58Z","timestamp":1408106638000},"page":"99-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular risk profile of veteran men beginning androgen deprivation therapy"],"prefix":"10.1016","volume":"32","author":[{"given":"Lindsay","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Litwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Maliski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jvn.2014.01.004_bib1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/95.13.981","article-title":"National practice patterns and time trends in androgen ablation for localized prostate cancer","volume":"95","author":"Cooperberg","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 1","key":"10.1016\/j.jvn.2014.01.004_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0090-4295(02)02397-X","article-title":"Side effects of androgen deprivation therapy: monitoring and minimizing toxicity","volume":"61","author":"Higano","year":"2003","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.jvn.2014.01.004_bib3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2008.08.054","article-title":"Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial","volume":"55","author":"Johansson","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.jvn.2014.01.004_bib4","first-page":"13","article-title":"Measuring hot flashes in men treated with hormone ablation therapy: an unmet need","volume":"26","author":"Kattan","year":"2006","journal-title":"Urol Nurs"},{"key":"10.1016\/j.jvn.2014.01.004_bib5","first-page":"217","article-title":"Long-term combined androgen blockade along for localized prostate cancer","volume":"3","author":"Labrie","year":"1999","journal-title":"Mol Urol"},{"issue":"3","key":"10.1016\/j.jvn.2014.01.004_bib6","first-page":"294","article-title":"Androgen-deprivation therapy in prostate cancer and cardiovascular risk","volume":"60","author":"Levine","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.jvn.2014.01.004_bib7","first-page":"641","article-title":"Androgen deprivation therapy\u2013managing side effects","volume":"37","author":"Kabir","year":"2008","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.jvn.2014.01.004_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1210\/jc.2004-1611","article-title":"The influence of androgen deprivation therapy on metabolism in patients with prostate cancer","volume":"90","author":"Nishiyama","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 1","key":"10.1016\/j.jvn.2014.01.004_bib9","first-page":"S34","article-title":"Metabolic complications of androgen deprivation therapy for prostate cancer","volume":"189","author":"Saylor","year":"2013","journal-title":"J Urol"},{"issue":"20","key":"10.1016\/j.jvn.2014.01.004_bib10","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/jnci\/djm168","article-title":"Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality","volume":"99","author":"Tsai","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jvn.2014.01.004_bib11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.eururo.2012.01.045","article-title":"Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism","volume":"61","author":"Hu","year":"2012","journal-title":"Eur Assoc Urol"},{"key":"10.1016\/j.jvn.2014.01.004_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/COC.0b013e318201a406","article-title":"Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes, and cardiovascular disease: a review","volume":"35","author":"Collier","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jvn.2014.01.004_bib13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ijrobp.2004.08.024","article-title":"Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy","volume":"61","author":"Beyer","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvn.2014.01.004_bib14","unstructured":"National Center for Veterans Analysis and Statistics. The Veteran population model. 2011; http:\/\/www.va.gov\/vetdata\/veteran_population.asp."},{"key":"10.1016\/j.jvn.2014.01.004_bib15","unstructured":"Howlader N, Noone AM, Krapcho M, et\u00a0al editors. SEER cancer statistics review, 1975-2010. Bethesda (MD): National Cancer Institute. April 2013; http:\/\/seer.cancer.gov\/csr\/1975_2010\/, Accessed November\u00a02012."},{"issue":"13","key":"10.1016\/j.jvn.2014.01.004_bib16","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/cncr.27941","article-title":"Agent Orange as a risk factor for high-grade prostate cancer","volume":"119","author":"Ansbaugh","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jvn.2014.01.004_bib17","unstructured":"NCI Dictionary of Cancer Terms. Gleason score. 2012; http:\/\/www.cancer.gov\/dictionary?cdrid=45696."},{"key":"10.1016\/j.jvn.2014.01.004_bib18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1353\/hpu.2012.0058","article-title":"Using the Framingham Risk Score to evaluate immigrant effect on cardiovascular disease risk in Mexican Americans","volume":"23","author":"Salinas","year":"2012","journal-title":"J Health Care Poor Underserved"},{"key":"10.1016\/j.jvn.2014.01.004_bib19","unstructured":"Agency for Healthcare Research and Quality. National Guidelines Clearinghouse: Guidelines by Topic. 2012; http:\/\/www.guideline.gov\/browse\/by-topic.aspx."},{"key":"10.1016\/j.jvn.2014.01.004_bib20","unstructured":"Framingham Heart Study. General cardiovascular disease: 10-year risk. 2011; http:\/\/www.framinghamheartstudy.org\/risk\/gencardio.html."},{"key":"10.1016\/j.jvn.2014.01.004_bib21","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/cncr.25751","article-title":"Overtreatment of men with low-risk prostate cancer and significant comorbidity","volume":"117","author":"Daskivich","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jvn.2014.01.004_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.286.2.180","article-title":"Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic group\u2019s investigation","volume":"286","author":"D\u2019Agostino","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jvn.2014.01.004_bib23","unstructured":"Office of the Actuary. Veteran population projections model.\u00a02011; http:\/\/www.va.gov\/vetdata\/docs\/QuickFacts\/Population_quickfacts.pdf."},{"issue":"1","key":"10.1016\/j.jvn.2014.01.004_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mayocp.2012.10.012","article-title":"Effect of physical activity and sedentary behavior on serum prostate-specific antigen concentrations: results from the National Health and Nutrition Examination Survey (NHANES), 2003-2006","volume":"88","author":"Loprinzi","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jvn.2014.01.004_bib25","unstructured":"U.S. Preventive Services Task Force. Screening for prostate cancer, topic page. 2012; http:\/\/www.uspreventiveservicestaskforce.org\/prostatecancerscreening.htm."},{"key":"10.1016\/j.jvn.2014.01.004_bib26","unstructured":"The Heart Institute of Doylestown Hospital. Framingham risk scoring sheet. http:\/\/www.cbfymca.org\/docs\/Framingham%20Risk%20Scoring%20Sheet.pdf."}],"container-title":["Journal of Vascular Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1062030314000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1062030314000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:20:48Z","timestamp":1761013248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1062030314000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1062030314000284"],"URL":"https:\/\/doi.org\/10.1016\/j.jvn.2014.01.004","relation":{},"ISSN":["1062-0303"],"issn-type":[{"type":"print","value":"1062-0303"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular risk profile of veteran men beginning androgen deprivation therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvn.2014.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}